Cargando…
We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity
Observational studies, from multiple countries, repeatedly demonstrate an association between obesity and severe COVID-19, which is defined as need for hospitalization, intensive care unit admission, invasive mechanical ventilation (IMV) or death. Meta-analysis of studies from China, USA, and France...
Autores principales: | Dutta, Nirjhar, Ingraham, Nicholas E., Usher, Michael G., Fox, Claudia, Tignanelli, Christopher J., Bramante, Carolyn T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930643/ https://www.ncbi.nlm.nih.gov/pubmed/33648370 http://dx.doi.org/10.1177/2150132721996283 |
Ejemplares similares
-
Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease
por: Tignanelli, Christopher J., et al.
Publicado: (2021) -
Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19.
por: Bramante, Carolyn T., et al.
Publicado: (2020) -
Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference
por: Ingraham, Nicholas E., et al.
Publicado: (2020) -
Endotracheal tube leak: What should we do?
por: Gupta, Nishkarsh
Publicado: (2015) -
Commentary: Coronary revascularization: How should we do it?
por: Sotolongo, Alex, et al.
Publicado: (2020)